Related Experiment Videos
[Hepatic amebiasis in French Polynesia. Study of 42 cases ].
Y Gendron1, F Chakhtoura, C Gras
1Medecin des Hôpitaux, Spécialiste, Clinique Cardella, Papeete, Tahiti, Polynésie Française.
Medecine Tropicale : Revue Du Corps De Sante Colonial
|January 1, 1992
Summary
Hepatic amoebiasis, a liver infection caused by Entamoeba histolytica, often presents with painful, enlarged liver and fever. Effective treatment involves nitro-imidazol compounds, with high recovery rates achieved through medical management and parasiticidal therapy.
Area of Science:
- Hepatology
- Infectious Diseases
- Parasitology
Context:
- Retrospective analysis of 42 hepatic amoebiasis cases in French Polynesia (1984-1990).
- Focus on clinical presentation, serological findings, anatomical characteristics, and treatment outcomes.
- Highlights the diagnostic utility of echotomography for intra-hepatic abscesses.
Purpose:
- To describe and analyze the clinical, serological, anatomical, and evolutive aspects of hepatic amoebiasis.
- To evaluate the effectiveness of different treatment modalities, including medical therapy and surgical intervention.
- To emphasize the importance of prompt diagnosis and appropriate management of liver abscesses caused by amoeba.
Summary:
- Painful hepatomegaly and fever were common presenting signs in hepatic amoebiasis.
- Amoebic serology was consistently positive, even when pathogenic amoeba was not detected in stool samples.
- Echotomography proved superior in diagnosing intra-hepatic collections, especially multiple abscesses.
- Recovery was consistently achieved with medical treatment (nitro-imidazoles) and parasiticidal therapy, with or without puncture.
Impact:
- Demonstrates high efficacy of nitro-imidazole compounds in treating hepatic amoebiasis.
- Underscores the importance of early diagnosis and comprehensive treatment strategies for improved patient outcomes.
- Provides valuable insights into the management of liver abscesses in endemic and non-endemic regions.